$VLY

Valley National Bancorp (VLY) Stock Net Interest Margin Gain Backs Bullish Efficiency Narrative

Simply Wall St reports Valley National Bancorp (VLY) opened Q2 2026 with Q2 revenue of $515.4M and basic EPS of $0.30, alongside net income of $163.6M. It cites Q2 2026 net interest margin of 3.2% and cost-to-income of 52.11% versus 3.01% and 55.2% a year earlier. Loans rose to $52.47B while nonperforming loans rose to $462.6M. Valuation cited: $14.34 price, $27.95 DCF fair value, 11.9x P/E.

Original reporting
Published Jul 24, 2026, 10:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 11:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Valley National Bancorp (VLY) Stock Net Interest Margin Gain Backs Bullish Efficiency Narrative — source image
Decision brief

The 30-second read

$VLYBullishLow
01

Why it matters

Traders can use the disclosed Q2 metrics to update short-term expectations for profitability quality (NIM, cost-to-income) while monitoring credit deterioration (non-performing loans vs total loans).

02

Market read

Provides concrete Q2 2026 operating and credit datapoints that influence valuation debate, but it does not introduce new guidance, deals, or regulatory actions.

03

What to watch

The piece does not quantify charge-offs, reserve build, or loan mix changes, which are critical to judging whether non-performing loan growth is transient or structural.

Relevance 4/10Novelty 4/10Timing: after-hours/late-day recap of Q2 2026 results and key metrics

Background

The article summarizes Valley National Bancorp’s Q2 2026 performance and frames it against investor narratives about efficiency and credit risk.

Company-level read

Ticker impact

$VLYBullishMedium confidence
Context

Valley National Bancorp reports Q2 2026 net interest margin at 3.2% and cost-to-income at 52.11%, improving vs Q2 2025.

Expected impact

Near-term bias modestly positive if investors prioritize margin and efficiency; downside risk persists if credit deterioration accelerates.

Evidence & confidence

The article provides specific Q2 2026 datapoints (NIM, cost-to-income, non-performing loans) that can shift how traders weigh profitability versus credit quality, though it is framed as analysis rather than a fresh guidance/regulatory event.

Market effects

Regional bank investors may re-balance toward efficiency metrics (cost-to-income) versus credit-quality signals (non-performing loans).

No specific regional macro or policy catalyst is cited beyond general regional bank concentration risk.

Limited global relevance; this is primarily a US regional bank fundamentals update.

Counterpoint

The margin and efficiency improvements may be offset by credit normalization risk, since non-performing loans rise alongside a larger loan book.

Key entities

  • Valley National Bancorp

    US regional bank holding company; article cites Q2 2026 NIM, cost-to-income, loan growth, and non-performing loan levels.

Related articles

$VLYMedAI 8/10

Valley National Bancorp (VLY) Q2 2026 Earnings Call Transcript

Valley National Bancorp (VLY) reported Q2 2026 net income of $170.9 million, or $0.29 per diluted share, up from $163.9 million in Q1. Adjusted net income was $172.8 million. Net interest margin rose to 3.2% and net interest income to $488.4 million. Loans grew to $52.5 billion and deposits to $54.1 billion. The CET1 ratio was 10.7%.

$VLYMed

VALLEY NATIONAL BANCORP (VLY): Results of Operations and Financial Condition

VALLEY NATIONAL BANCORP (VLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991earningsrelease0.htm EX-99.1 Document Exhibit 99.1 News Release FOR IMMEDIATE RELEASE Contact: Travis Lan Senior Executive Vice President and Chief Financial Officer 973-686-5007 VALLEY NATIONAL BANCORP ANNOUNCES SECOND QUARTER 2026 RESULTS NEW YORK, NY – July

$LLYMedAI 8/10

Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly (LLY) reported Q2 U.S. revenue up 33% led by ZEPBOUND and MOUNJARO volume, while U.S. price fell 3% (9% excluding rebate and discount estimate changes). International revenue rose in constant currency, with MOUNJARO a key driver. Lilly raised its 2026 revenue outlook to $85B-$87B and guided non-GAAP EPS $35.50-$36.50. It also discussed Medicare GLP-1 coverage expansion and retatrutide Phase III results.

$BRK-BMed

Berkshire Hathaway Just Did Something It Hasn’t Done in More Than 3 Years

Berkshire Hathaway reported Q2 2026 cash and Treasury bills of $365.5 billion, down from $397.4 billion in Q1, ending a 14-quarter streak as a net seller. According to Berkshire, CEO Greg Abel became a net buyer of equities, adding about $20 billion net, and increased buybacks to $4.5 billion. Apple fell to 20% of the portfolio; Alphabet rose after a $10 billion investment.

$LIONMed

Lionsgate Studios Q1 Earnings Call Highlights

Lionsgate (NYSE:LION) Q1 earnings call said it expects downstream revenue from films through fiscal 2027 and that The Hunger Games: Sunrise on the Reaping could support later-year results. Television revenue was $189 million, segment profit $10 million. Trailing 12-month library revenue was $987 million, backlog $1.5 billion. Net debt fell $121 million to about $1.5 billion; leverage improved to 4.3x.

$ENBMed

Enbridge Delivers Strong Q2 Results: Is the Stock Still a Buy?

Enbridge reported Q2 2026 results, with adjusted earnings of $1.4B, or $0.63 per share, roughly matching last year’s $0.65. Adjusted EBITDA rose to $4.8B from $4.6B. Operating cash flow increased to $4.1B from $3.2B. The company reaffirmed full-year guidance, added $1B to a $41B growth backlog, sanctioned Line 5 relocation and signed an option for the TTC Connector Pipeline.